These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7106459)

  • 1. [Piretanide in the therapy of water-sodium retention in hepatic cirrhosis].
    Scarpioni L; Crippa G; Zanazzi MA
    G Clin Med; 1982 Jan; 63(1):57-76. PubMed ID: 7106459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disorders of water-electrolyte balance in chronic hepatitis and liver cirrhosis].
    Dederer IuM; Rozhkova TA
    Ter Arkh; 1975; 47(2):72-8. PubMed ID: 1145463
    [No Abstract]   [Full Text] [Related]  

  • 4. [Water-electrolyte disorders and their importance in the etiopathogenesis and physiopathology of edemas].
    Del Nero Júnior E; Lima EV
    Arq Bras Cardiol; 1981 Jan; 36(1):59-71. PubMed ID: 7023432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various indicators of water-electrolyte metabolism in ulcer and cancer of the stomach].
    Komakhidze ME; Akhmeteli TI; Papava RI
    Vestn Khir Im I I Grek; 1977 Mar; 118(3):126-7. PubMed ID: 878179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Quoidbach A; Busset R; Jenny M
    Praxis; 1969 Sep; 58(38):1197-201. PubMed ID: 4910991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in renal function and the intracellular environment in cirrhotic patients].
    Tiberio López G; Tanco S; Orradre B; Berrade MF; Anderiz López M
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):367-78. PubMed ID: 2988084
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrolyte metabolism anomalies in liver cirrhosis].
    Okumura M; Katsuki S
    Saishin Igaku; 1968 Dec; 23(12):2527-33. PubMed ID: 4889816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC
    Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system.
    Krag A; Møller S; Pedersen EB; Henriksen JH; Holstein-Rathlou NH; Bendtsen F
    Liver Int; 2010 Oct; 30(9):1364-70. PubMed ID: 20731774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disordered sodium metabolism: sodium retention states.
    Cadnapaphornchai P
    Crit Care Clin; 1987 Oct; 3(4):779-95. PubMed ID: 3332224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of structured water and associated cations in cells (ther tissue damage syndrome) and its medical treatment.
    Cope FW
    Physiol Chem Phys; 1977; 9(6):547-53. PubMed ID: 614594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology and treatment of ascites in the cirrhotic patient].
    Rodés J; Arroyo V
    Rev Med Brux; 1987 Apr; 8(4):204-8. PubMed ID: 3589268
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic possibilities and risks in hepatic cirrhosis with water-electrolyte metabolism disorders].
    Schwartz M; Fodor O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(3):219-25. PubMed ID: 770
    [No Abstract]   [Full Text] [Related]  

  • 15. [Balance and limits of the distribution of potassium, osmotically active sodium and water. Clinical studies of normal and pathologic variations].
    Leppla W
    Ann Univ Sarav Med; 1966; 13(4):183-261. PubMed ID: 5991413
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the oral diuretics, aminometradine and aminoisometradine, in the sodium and water retention of hepatic cirrhosis.
    WATSON DD; BALFOUR DC
    Gastroenterology; 1957 Aug; 33(2):202-8. PubMed ID: 13462067
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
    Bissoli F; Gini G; Bosio M; Ceriani R
    Recenti Prog Med; 1996 May; 87(5):227-8. PubMed ID: 8767760
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of the hepatorenal syndrome with metaraminol.
    Sugerman HJ; Berkowitz HD; Davidson DT; Miller LD
    Surg Forum; 1970; 21():359-61. PubMed ID: 5514762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autogenous intravenous infusion of ascitic fluid in patients with liver cirrhosis].
    Selmi W
    Minerva Med; 1973; 64(53):2764-74. PubMed ID: 4726749
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY; Schrier RW
    Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.